GlassScriptPhysician profile
Awail U Sadiq
NPI 1437412566
$10,837.43
in general payments reported to CMS, 2019-2025
31 companies · $847 in 2025
The $847 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,120 · 2020: $2,987 · 2021: $432 · 2022: $648 · 2023: $2,148 · 2024: $655 · 2025: $847.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,194 · Travel and Lodging: $1,442 · Education: $13.82.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,194.30 |
| Travel and Lodging | $1,442.47 |
| Education | $13.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $4,027.16 | 2019-2020 | |
| Medtronic, INC. | $2,215.93 | 2021-2025 | Micra, Symplicity G3, Selectsecure |
| Edwards Lifesciences Corporation | $1,587.62 | 2019-2024 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Cardiovascular Systems INC. | $823.14 | 2019-2023 | Diamondback Coronary |
| Novartis Pharmaceuticals Corporation | $352.30 | 2022-2025 | |
| Boston Scientific Corporation | $349.64 | 2019-2025 | Bodyguardian, Watchman Access System, Varithena Administration Pack |
| Amgen INC. | $156.22 | 2023-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $151.40 | 2022-2025 | Eliquis |
| Pfizer INC. | $142.82 | 2022-2025 | |
| Teleflex LLC | $120.17 | 2023 | Guideliner, Trapliner |
| Irhythm Technologies, INC. | $112.19 | 2022-2024 | Zio Monitor, Zio Xt Patch |
| Novo Nordisk INC | $81.22 | 2024-2025 | Wegovy |
| Cook Medical LLC | $79.98 | 2020-2023 | Tornado |
| Boehringer Ingelheim Pharmaceuticals, INC. | $71.91 | 2024-2025 | Jardiance |
| Angiodynamics, INC. | $68.48 | 2022-2024 | Alphavac |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $55.78 | 2023 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $48.64 | 2024 | Farxiga |
| Davol INC. | $46.97 | 2020 | |
| Abbott Laboratories | $39.62 | 2024-2025 | Thoratec Heartmate II, Lvas Implant Kit, Perclose Proglide |
| W. L. Gore & Associates, INC. | $36.98 | 2020-2023 | Gore Excluder Aaa Endoprosthesis |
| Lilly USA, LLC | $34.51 | 2025 | Zepbound, Mounjaro |
| Daiichi Sankyo INC. | $30.65 | 2024 | Injectafer |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $29.18 | 2024-2025 | Lifevest |
| Cleerly, INC. | $27.54 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Acist Medical Systems, INC. | $25.78 | 2022 | |
| Inspire Medical Systems, INC. | $22.48 | 2025 | Inspire |
| Kiniksa Pharmaceuticals International, Plc | $21.53 | 2024 | Arcalyst |
| Abiomed | $20.36 | 2024 | Impella |
| Bard Peripheral Vascular, INC. | $19.79 | 2021 | |
| Scpharmaceuticals INC. | $19.69 | 2023 | |
| Janssen Pharmaceuticals, INC | $17.75 | 2024 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Awail Sadiq listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.